TerminatedPHASE1, PHASE2NCT01024686

Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria Vaccine

Studying Malaria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Seattle Children's Hospital
Principal Investigator
Michele Spring, M.D., MD
Walter Reed Army Institute of Research (WRAIR)
Intervention
p52-/p36- GAP Vaccine(biological)
Enrollment
6 enrolled
Eligibility
18-50 years · All sexes
Timeline
20102011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01024686 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria

← Back to all trials